Amneal Pharmaceuticals, Inc. (AMRX)
NASDAQ: AMRX · Real-Time Price · USD
7.61
-0.01 (-0.13%)
Jun 9, 2025, 4:00 PM - Market closed
Amneal Pharmaceuticals Employees
Amneal Pharmaceuticals had 8,300 employees as of December 31, 2024. The number of employees increased by 450 or 5.73% compared to the previous year.
Employees
8,300
Change (1Y)
450
Growth (1Y)
5.73%
Revenue / Employee
$340,986
Profits / Employee
-$1,572
Market Cap
2.39B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
| AbbVie | 55,000 |
AMRX News
- 11 days ago - Amneal to Participate at Upcoming Investor Conferences in June - GlobeNewsWire
- 25 days ago - US FDA approves Amneal's migraine treatment - Reuters
- 25 days ago - Amneal Receives U.S. FDA Approval for Brekiya® (dihydroergotamine mesylate) injection for the Acute Treatment of Migraine and Cluster Headaches in Adults - GlobeNewsWire
- 4 weeks ago - Amneal and Apiject to Expand Sterile and Blow-Fill-Seal (BFS) Capabilities for Advanced Pharmaceutical Manufacturing in the U.S. - GlobeNewsWire
- 5 weeks ago - Amneal Pharmaceuticals, Inc. (AMRX) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 5 weeks ago - Amneal Reports First Quarter 2025 Financial Results - Business Wire
- 2 months ago - Amneal Donates $1.5 Million to Support Patients During Parkinson's Awareness Month - Business Wire
- 2 months ago - Amneal to Report First Quarter 2025 Results on May 2, 2025 - Business Wire